赛尔图因的激活和抑制:从长椅到床边
Francesco Fiorentino1, Emanuele Fabbrizi1, Antonello Mai1,2
1Department of Drug Chemistry and Technologies, Sapienza University of Rome, Rome, Italy.
Medicinal research reviews
|August 31, 2024
概括
赛尔图因是依赖NAD+的酶,调节关键的细胞过程和衰老. 调节sirtuins为代谢,心血管和神经退行性疾病以及癌症提供治疗潜力.
科学领域:
- 生物化学 生化学
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 赛尔图因是依赖NAD+的酶,调节基因稳定性,基因表达,新陈代谢和衰老.
- 赛尔图因的失调与代谢,心血管,神经疾病和癌症有关.
- 赛尔图因在癌症中表现出上下文依赖的作用,作为瘤抑制剂或促进剂.
研究的目的:
- 提供关于sirtuin药理学,酶活性和生物功能的关键见解.
- 审查相关的Sirtuin调节剂,包括它们的机制,结构-活性关系和影响.
- 讨论Sirtuin调节在与年龄相关的疾病和癌症中的治疗潜力.
主要方法:
- 关于Sirtuin生物学和药理学的文献综述.
- 分析sirtuins的酶活性和生物功能.
- 概述锡尔图因调节剂的结构-活性关系和药理作用.
主要成果:
- 赛尔图因对细胞平衡和生物体健康至关重要.
- 赛尔图因调制显示出糖尿病,心血管/神经退行性疾病和癌症的治疗前景.
- 异形选择性调节剂可以促进对Sirtuin生物学和治疗开发的理解.
结论:
- 赛尔图因调节器代表了对各种疾病的有前途的治疗策略.
- 需要对异形选择性Sirtuin调制剂进行进一步的研究.
- 了解sirtuin的药理学是开发有效治疗年龄相关疾病和癌症的关键.
相关概念视频
The JAK-STAT Signaling Pathway
8.7K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.7K
Inhibition of Cdk Activity
4.7K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K
PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Covalently Linked Protein Regulators
6.8K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
These groups modify specific amino acids in a protein....
6.8K
NF-κB-dependent Signaling Pathway
7.4K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.4K


